Fig. 8
From: UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma
Prediction of chemosensitivity in the TCGA-LUAD cohort using the prognostic signature. Comparison of IC50 of common chemotherapeutic drugs between high- and high-risk groups, including cisplatin (A), docetaxel (B), gemcitabine (C), paclitaxel (D), erlotinib (E), and gefitinib (F)